Oct 9, 2026 08:01AM
Oct 9, 2026 08:00AM
Oct 9, 2026 06:06AM
Sep 22, 2026 01:52AM
Aug 14, 2026 08:00AM
Jun 25, 2026 07:28AM
Jun 25, 2026 07:28AM Quince Therapeutics (QNCX) Reiterated at Overweight by Cantor Fitzgerald Post Orphai Acquisition
Jun 24, 2026 06:23AM
Jun 23, 2026 06:43AM
May 18, 2026 10:22AM
May 18, 2026 10:21AM
May 18, 2026 09:27AM
May 18, 2026 09:26AM
May 18, 2026 09:26AM Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
May 18, 2026 09:26AM
Mar 30, 2026 08:32AM
Mar 30, 2026 08:30AM
Apr 1, 2024 07:00AM
Feb 15, 2024 07:03AM
Feb 15, 2024 07:00AM
Oct 23, 2023 07:00AM Quince Therapeutics Completes Acquisition of EryDel S.p.A.
Sep 28, 2023 04:05PM
Sep 28, 2023 04:05PM
Sep 6, 2023 07:03AM
Sep 6, 2023 07:00AM
Jul 24, 2023 07:04AM
Jul 24, 2023 07:00AM
Jul 13, 2023 08:05AM Echo Lake Capital Increases Offer to Acquire Quince Therapeutics (QNCX) to $1.80/sh plus CVR
Jul 13, 2023 08:00AM
Jun 6, 2023 08:00AM
Apr 11, 2023 07:01AM
Apr 11, 2023 07:00AM
Apr 6, 2023 04:05PM
Apr 5, 2023 04:06PM
Apr 5, 2023 04:05PM Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan
Mar 22, 2023 05:53AM
Mar 22, 2023 05:00AM
Mar 21, 2023 08:04AM
Mar 21, 2023 08:00AM
Jan 30, 2023 04:05PM
Jan 27, 2023 08:42AM
Jan 27, 2023 08:00AM Quince Therapeutics Completes the Sale of Legacy Protease Inhibitor Portfolio to Lighthouse Pharmaceuticals
Aug 1, 2022 08:13AM
Aug 1, 2022 08:00AM

1,199,260 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All